Palliative Care for Chronic Kidney Disease

Not yet recruiting at 1 trial location
JS
RM
Overseen ByRachel Monahan
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of study is to investigate whether adding palliative care to usual chronic kidney disease (CKD) care improves symptoms and quality of life for people with CKD. The primary objectives are to 1) determine efficacy of Kidney Palliative Care (KPC) integrated with CKD care on symptom burden compared with usual CKD care, 2) identify clinical and demographic factors associated with differential responses to KPC, and 3) characterize participant and provider experiences with kidney care and factors influencing implementation.

Who Is on the Research Team?

JS

Jennifer Scherer, MD, MS, FASN

Principal Investigator

NYU Langone Health

Are You a Good Fit for This Trial?

This trial is for adults with chronic kidney disease (CKD). Participants should be receiving regular CKD care. People who have other serious illnesses or conditions that would prevent them from participating may not be eligible.

Inclusion Criteria

Speak Spanish or English, and report at IPOS-Renal score of ≥ 3 on a screening survey
Receive care at nephrology clinics or dialysis centers associated with each site
I have severe kidney disease or am on long-term dialysis.
See 1 more

Exclusion Criteria

Pregnant individuals
Non-English and Non-Spanish speakers to correspond with the populations most impacted by CKD in the US
Enrolled in hospice
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • Kidney RISE

Trial Overview

The study compares usual care for CKD to usual care plus extra support called Kidney Palliative Care, which focuses on managing symptoms and improving quality of life. Participants are randomly assigned to one of the two groups.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Integrated Kidney Palliative CareExperimental Treatment1 Intervention
Group II: Usual Chronic Kidney Disease (CKD) CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+